Principal Financial Group
CBPO

Principal Financial Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Principal Financial Group’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,984
Closed -$1.99M – 2269
2016
Q3 		$1.99M Sell
15,984
-267,218
-94% -$31.5M ﹤0.01% 1679
2016
Q2 		$30.1M Buy
283,202
+93,796
+50% +$10.9M 0.04% 431
2016
Q1 		$21.7M Buy
189,406
+1,326
+0.7% +$156K 0.03% 554
2015
Q4 		$26.8M Sell
188,080
-140,789
-43% -$16.3M 0.04% 438
2015
Q3 		$29.5M Buy
328,869
+199,000
+153% +$21M 0.05% 395
2015
Q2 		$15M Buy
+129,869
New +$13.6M 0.02% 722

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Principal Financial Group's CBPO Position: Q4 2016 in Review

Principal Financial Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2016, closing a stake of 15,984 shares — an estimated $1.99M sold.

Principal Financial Group first reported a position in CBPO in Q2 2015 and held it in 6 quarters. The position peaked at $30.1M in Q2 2016. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

  • Principal Financial Group reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
  • Principal Financial Group sold 15,984 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $1.99M.
  • Principal Financial Group first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 6 quarters.
  • Principal Financial Group's China Biologic Products Holdings, Inc. position peaked at $30.1M in Q2 2016.
  • 143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on Principal Financial Group's 13F filing for Q4 2016, filed 13 Feb 2017.